Report Categories
View AllRecent Articles
View All
Deutsche Bank Aktiengesellschaft DB Posts Robust Q1 2026 Results Reaffirms 2028 Financial Targets
The market opportunity Namib NAMMW is chasing Parabolic 20260505
What Option OPCH is doing that separates it from the herd Slips 20260506
BDCIW BTC Warrant releases no formal quarterly earnings data market participants hold off on nearterm trading calls
UK Trade Deficit With US Emerges as Exports Plunge 25 Following Trump Tariffs
Fed Holds Rates Steady Amid Divided Decision
Stephen Millers Deficit Blame Game Immigration vs Fiscal Reality
Colombia Violence Claims at Least 52 Lives Raising Security and Economic Concerns
Analysts Adjust Snowflake Price Targets Ahead of Quarterly Earnings Report
Solanas LongTerm Outlook Analysts Weigh Network Growth and Market Challenges
ADXN Q1 2024 Earnings PreRevenue Biotech Reports Net Loss Amid Ongoing RD Efforts
FiscalNote Q1 2026 Earnings EPS Surprise Beats Estimates Despite Stock Decline
Birchtech Corp BCHT Q1 2026 Earnings EPS Falls Short of Estimates Stock Slips
Shattuck Labs Q1 2026 Earnings NarrowerThanExpected Loss Amid Pipeline Progress
Sarepta Therapeutics Q1 2026 Earnings Robust EPS Beat Amid Modest Market Caution
GIL Q1 2026 Earnings EPS Surpasses Estimates with Strong Operational Execution
Corvex Inc MOVE Drops 865 Key Support Levels in Focus After Heavy Selloff
Candel Therapeutics CADL Edges Higher Holds Above Key Support Level
Digital Realty Trust DLR Holds Near Resistance as Volatility Remains Low
Qfin Holdings QFIN Surges 26 in Strong Rally Testing Key Resistance Levels
Blue Ridge Bankshares BRBS Holds Steady Near Support After Marginal Advance
UWMC Q1 2026 Earnings EPS Surges Past Estimates Amidst Quiet Revenue Reporting
ONC Q4 2025 Earnings EPS Misses Estimates by Wide Margin Stock Slides 25
Oppenheimer Holdings Inc OPY Q1 2025 Earnings EPS of 272 Reflects Operational Discipline Amid Revenue Uncertainty
Roblox Q1 2026 Earnings EPS Surprise Beats Estimates Stock Rises
Urban One Inc UONE Q1 2026 Earnings Negative EPS Amidst Limited Disclosure
CNTA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues RD Investment